The Journal of Pediatric Research

Occult Muscle Disease Should be Considered In Children With Unexplained Persistent Hypertransaminasemia []
. 2018; 5(1): 57-59

Occult Muscle Disease Should be Considered In Children With Unexplained Persistent Hypertransaminasemia

Naglaa Mohamed Kamal1, Muhammad Rafique2, Abidi Kamel3, Laila Metwally Sherif4
1Pediatric Hepatology Department, Faculty Of Medicine, Cairo University, Cairo, Egypt.
2Pediatric Department, Alhada Armed Forces Hospital, Taif, Ksa.
3Nephropediatric Department, Faculty Of Medecine, Tunis Al Manar University, Tunisia.
4Pediatric Department, Faculty Of Medicine, Zagazig University, Zagazig, Egypt.

An asymptomatic 4.5 years old Saudi female child was referred to the Pediatric Hepatology and Gastro-enterology clinic of Al Hada Armed Forces Hospital, KSA with presumed liver disease because of persistently elevated transaminases which were discovered accidently during routine laboratory workup. Alanine aminotransferase (ALT) was 128 IU/L and aspartate aminotransferase (AST) was 143 IU/L. Subsequent investigation in the hepatology clinic revealed normal hepatic workup. Muscle related workup revealed increased Creatine Phosphokinase (CPK), abnormal EMG and motor nerve conduction. Muscle biopsy was suggestive of early stage of muscular dystrophy and immunochemical analyses were compatible with limb-girdle-muscle-disease type 2C. Further confirmation by molecular genetic testing was done. Ultimately limb-girdle-muscle-dystrophy-2C was confirmed with the characteristics of specific abnormalities in muscle biopsy. This case demonstrates that increased transaminases do not always suggest liver disease and occult muscle disease should always be taken into account while investigating patients with unexplained persistent hypertransaminasemia.

Keywords: Aminotransferases, Children, Creatine Phosphokinase, Myopathy


Naglaa Mohamed Kamal, Muhammad Rafique, Abidi Kamel, Laila Metwally Sherif. Occult Muscle Disease Should be Considered In Children With Unexplained Persistent Hypertransaminasemia. . 2018; 5(1): 57-59

Corresponding Author: Naglaa Mohamed Kamal, Saudi Arabia


TOOLS
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar